Showing results (111-120 of 174) with videos related to
Sort By:
Pageof 18
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|February 10, 2012
Uterine leiomyosarcoma producing granulocyte colony stimulating factorKentaro Nakayama, Naomi Nakayama, Mohammed Tanjimur Rahman, et al.International Journal of Oncology|December 10, 2015
CCNE1 amplification is associated with aggressive potential in endometrioid endometrial carcinomasKentaro Nakayama, Mohammed Tanjimur Rahman, Munmun Rahman, et al.Molecular and Clinical Oncology|February 20, 2018
High preoperative Glasgow prognostic score is a negative prognostic factor for patients with endometrial carcinomaKohei Nakamura, Kentaro Nakayama, Toshiko Minamoto, et al.Oncology Reports|February 22, 2008
Genetic classification of ovarian carcinoma based on microsatellite analysis: relationship to clinicopathological features and patient survivalZhang Huan, Kentaro Nakayama, Naomi Nakayama, et al.The Journal of Pathology|November 22, 2011
Low-grade serous carcinomas of the ovary contain very few point mutationsSiân Jones, Tian-Li Wang, Robert J Kurman, et al.American Journal of Clinical Pathology|September 27, 2012
Notch3 overexpression as potential therapeutic target in advanced stage chemoresistant ovarian cancerMohammed Tanjimur Rahman, Kentaro Nakayama, Munmun Rahman, et al.Oral Oncology|January 3, 2003
Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) as a chemoresistance marker in human oral squamous cell carcinoma treated with cisplatinHitoshi Miyashita, Yasutaka Nitta, Shiro Mori, et al.Human Pathology|June 19, 2012
Clinicopathologic and biological analysis of PIK3CA mutation in ovarian clear cell carcinomaMunmun Rahman, Kentaro Nakayama, Mohammed Tanjimur Rahman, et al.Pathology International|December 21, 2012
Low expression of nucleus accumbens-associated protein 1 predicts poor prognosis for patients with pancreatic ductal adenocarcinomaTakeshi Nishi, Riruke Maruyama, Takeshi Urano, et al.Current Oncology (Toronto, Ont.)|May 27, 2022
Mutation Profiles of Ovarian Seromucinous Borderline Tumors in Japanese PatientsHiroki Sasamori, Kentaro Nakayama, Sultana Razia, et al.Pageof 18